Table 3. A linear regression of the clinical and laboratory characteristics according to the GFRs of the 142 patients with predialysis CKD.
| Characteristic | GFR | |||
|---|---|---|---|---|
| Univariate analysis | Adjusted by BMI | |||
| β coefficient | p-value | β coefficient | p-value | |
| Clinics | ||||
| Age (years old) | 0.03 | 0.625 | ||
| Gender (F > M) | 6.9 | 0.001 | 6.1 | 0.005 |
| BMI* | 24.1 | 0.000 | ||
| Diabetes (Yes > No) | 1.4 | 0.546 | ||
| Use of a statin (Yes > No) | 3.0 | 0.171 | 2.9 | 0.183 |
| Number of medication | 0.43 | 0.408 | ||
| Laboratory | ||||
| AST/ULN* | 8.87 | 0.007 | 8.40 | 0.008 |
| ALT/ULN* | 5.06 | 0.028 | 4.58 | 0.039 |
ULN: upper limit of normal
*Logarithmic transformation